Top Markets
#1 Purr Purr +59.03%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Pons Pons +35.37%
#4 Kinetiq Kinetiq +28.28%
#5 ApeX ApeX +24.56%
#6 Non-Playable Coin Non-Playable Coin +20.51%
#7 Morpho Morpho +19.21%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +18.77%
#9 OriginTrail OriginTrail +18.36%
#10 Pudgy Penguins Pudgy Penguins +18.08%
Coin of the day
Purr Purr
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc.

TALS
Classifica tra le azioni #21258
Talaris Therapeutics, Inc. is a cell therapy company operating in the United... Talaris Therapeutics, Inc. is a cell therapy company operating in the United States, currently in its late clinical development stages. Its mission involves pioneering an allogeneic hematopoietic stem cell transplantation strategy designed to revolutionize treatment paradigms for solid organ transplantation, severe autoimmune conditions, and significant non-malignant blood, immune, and metabolic disorders. The company's flagship product, FCR001, is an innovative allogeneic cell therapy presently in Phase II clinical trials for patients undergoing living donor kidney transplantation. Beyond this, Talaris Therapeutics is actively advancing FCR002 for use in deceased donor kidney transplants, investigating FCR001 for individuals with a severe form of scleroderma, and exploring its applicability for a range of other serious non-malignant blood, immune, or metabolic conditions. Founded in 1988, the company maintains its headquarters in Louisville, Kentucky.
Prezzo delle azioni
$2.72
Ultima sincronizzazione: 2023-10-19
Capitalizzazione di mercato
$111.47M
Variazione (1 giorno)
-0.73%
Variazione (1 anno)
0.00%
Paese
US
Scambia Talaris Therapeutics, Inc. (TALS)

Categoria

Healthcare
Il prezzo TALS con la capitalizzazione del mercato della B
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.
TALS
$2.72
Capitalizzazione di mercato di Talaris Therapeutics, Inc.(TALS)
Capitalizzazione di mercato: $111.47M
A partire dal August 2026, Talaris Therapeutics, Inc. ha una capitalizzazione di mercato pari a $111.47M. Questo rende Talaris Therapeutics, Inc. la 21258th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Talaris Therapeutics, Inc. dal 2021 al 2026
TALS in paragone con la classifica dei più popolari stocks
Il prezzo per TALS Attivo B Capitalizzazione del mercato a B Risultati
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.
$127,168 $111.47M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.211T +4,675,210.91%
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.
$110,950 $111.47M
Apple Inc. Apple Inc.
AAPL
$4.547T +4,078,953.24%
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.
$101,573 $111.47M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +3,734,210.45%
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.
$87,671.72 $111.47M
Microsoft Corporation Microsoft Corporation
MSFT
$3.593T +3,223,124.84%
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.
$68,151.57 $111.47M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.793T +2,505,472.44%